申请人:BHARAT BIOTECH INTERNATIONAL LIMITED
公开号:US10576147B2
公开(公告)日:2020-03-03
The invention relates to novel Muramyl Dipeptide (MDP) derivative compound of structural Formula-VIII, a process for synthesis, intermediates used in the synthesis and use thereof;
wherein R1 and R2 both are hydrogen; or R1 is hydrogen and R2 is alkyl or aryl; or R1 is alkyl or aryl and R2 is hydrogen; or R1 and R2 both are alkyl or aryl (same or different groups); wherein alkyl group constitute C1-C6 alkyl or higher (both linear and branched) with or without heteroatoms; and aryl group constitute phenyl, substituted phenyl, heteraryl, arylalkyl and polynuclear aromatics. These compounds possess excellent pharmacological properties, in particular immunomodulating properties for use as adjuvant in vaccine formulations. These compounds are, particularly useful as adjuvants in vaccines.
本发明涉及结构式-VIII 的新型 Muramyl 二肽 (MDP) 衍生物化合物、合成工艺、合成中使用的中间体及其用途;
其中 R1 和 R2 均为氢;或 R1 为氢,R2 为烷基或芳基;或 R1 为烷基或芳基,R2 为氢;或 R1 和 R2 均为烷基或芳基(相同或不同基团);其中烷基为 C1-C6 烷基或更高的烷基(包括直链和支链),含或不含杂原子;芳基为苯基、取代苯基、杂芳基、芳烷基和多核芳烃。这些化合物具有优异的药理特性,特别是免疫调节特性,可用作疫苗制剂中的佐剂。这些化合物尤其可用作疫苗佐剂。